Friday, 18 Oct 2019

Drug Safety

Date Typesort ascending Title Save
04 Nov 2017 Social RT @isa75012: Major risk factors for retinal toxicity from HCQ. #ACR17 @RheumFellows https://t.co/lqWbk3iT3c
29 Dec 2017 Social Tramadol dosing: max is 400 mg/d. For those >75 yrs, the max is 300 mg/d; those w/ CKD (<30 mL/min) max dose=200 mg/d https://t.co/vfIlshFX0m
22 Mar 2016 Social FDA proposes ban on powdered gloves citing more adverse events, airway & wound inflammation & postsurgical adhesions https://t.co/v16noXzkcY
11 Jul 2016 Social 100k German RA compared to 500k controls: RA pts vaccinated more; more pneumonia hospitalizations w/ no vaccination https://t.co/HxOIIOf0rP
30 Nov 2016 Social RT @CCalabreseDO: Study shows that only 1/5 of seniors receive shingles vaccine https://t.co/urTtxoc4MH
03 Sep 2015 Social Drs Cush & Tesser review limited treatment options in a difficult RA pt w/ coexistant Coccidioidomycosis. http://t.co/iKwF30Yhqf
28 Aug 2019 Social RT @dcmarbury: Wow. Just wow. This is frigging terrible. How has this flown under the radar for so long? #greed #corruption #pbms #terri…
26 Jan 2018 Social Bosentan may be effective in treating cutaneous ulcers with Anti-MDA5 Dermatomyositis. https://t.co/c5C1Vi5LVh
11 Oct 2018 Social Ustekinumab is already approved for Crohn's colitis, now shows efficacy in 960 refractory ulcerative colitis patients given 2 doses of 130 mg sc https://t.co/5ILFRAwOcZ
29 Apr 2017 Social #SOTA2017 Dr Bingham John's Hopkins case experiences, pts tx for metastatic refractory cancer with ICI https://t.co/ep2D2tunPf
24 Apr 2016 Social ID maven Dr. Kevin Winthrop has 5 Dos & Donts on Vaccine Use in Rheum pts - high dose flu, when to use Prevnar, etc https://t.co/y2J3YEJbYB
25 Aug 2017 Social RheumNow Wk in Review is up! Or do the podcast on iTunes or https://t.co/K5fWS8nlU9 here - give us a good review! https://t.co/0SUZ3hbZMN
06 Nov 2017 Social RT @psufka: No difference in outcomes compared to baseline for pts exposed to certolizumab during 1st tri of pregnancy #ACR17 @rheumnow #13…
14 Jul 2015 Social Drug Safety DONTs:1) use anothers pills; 2) change dosingt; 3) crush tablets; 4) ignore expire date; 5) store in heat http://t.co/RXiBA4jQgB
10 Feb 2018 Social Dr Mark Genovese #RWCS - the rate of venous thromboembolic everts with baricitinib exposure appears to be 0.5 events per 100PY (basically the same rate seen in RA alone 0.5/100 PY) https://t.co/fRvLpHuDFP
24 Oct 2018 Social RT @CCalabreseDO: incidence of hypogam with rituximab is low but progressively identified overtime. infection rates remain low. abstract #2…
29 Apr 2017 Social #SOTA2017 Dr Sherine Gabriel retrospective cohort study suggests acute MI risk maybe be lower with a be abatacept c… https://t.co/HUcdwHjMUS
08 Apr 2019 Social Long term safety study of 4481 tofacitinib pts w/ 9.5yrs exposure (16,291PYs). 52% discontinued Rx (4% insufficient response; 24% adverse events). AE incidence rates were 3.4/100PY for H zoster, 2.4/100Py SIE, 0.8 cancer, 0.4 MACE, 0.3 Mortality. https://t.co/Qv5keuKXr3
25 Oct 2018 Social RT @psufka: Even low dose prednisone (5mg/day) associated with increased cumulative risk of infection #ACR18 @rheumnow https://t.co/UULnw8L…
13 May 2016 Social FDA warns that serious side effx of fluoroquinolones obviates use in sinusitis, bronchitis, UTI (safer Rx options) https://t.co/lWLyBfbd5V